SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-13-037745
Filing Date
2013-07-24
Accepted
2013-07-24 17:49:09
Documents
1
Period of Report
2013-07-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4828
  Complete submission text file 0001209191-13-037745.txt   6222
Mailing Address TARGETED GENETICS CORP 1100 OLIVE WAY STE 100 SEATTLE WA 98101
Business Address
LACASSE LOUIS P (Reporting) CIK: 0001216489 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36003 | Film No.: 13984433

Mailing Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121
Business Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121 (858) 558-8130
Conatus Pharmaceuticals Inc (Issuer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations